Nuvasive reported $225.98M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Abiomed ABMD:US $ 180.49M 47.67M
Atricure ATRC:US $ 54.56M 26.42M
Baxter International BAX:US $ 1852M 442M
Becton, Dickinson and BDX:US $ 2558M 589M
Cardiovascular Systems CSII:US $ 66.42M 0.53M
Cooper Companies COO:US $ 399.2M 118.5M
Dexcom DXCM:US $ 735.4M 19.4M
Edwards Lifesciences EW:US $ 1198.1M 167.2M
Globus Medical GMED:US $ 150.77M 79.02M
Haemonetics HAE:US $ 259.5M 22.62M
Hologic HOLX:US $ 2375.3M 84.5M
Inogen INGN:US $ 223.62M 10.22M
Insulet PODD:US $ 551.2M 49.5M
Integra Lifesciences IART:US $ 447.15M 40.06M
Intuitive Surgical ISRG:US $ 8175.4M 7651.7M
Medtronic MDT:US $ 3714M 235M
Merit Medical Systems MMSI:US $ 63M 9.13M
Nuvasive NUVA:US $ 225.98M 20.67M
Orthofix International OFIX:US $ 59.54M 12.38M
Stryker SYK:US $ 1044M 414M
Tandem Diabetes Care TNDM:US $ 114.97M 21.28M
Teleflex TFX:US $ 308.12M 158.54M
Zimmer Biomet Holdings Inc ZBH:US $ 386.4M 49.4M